These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis. Pohl U; Wagenknecht B; Naumann U; Weller M Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342 [TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells. Roth W; Wagenknecht B; Dichgans J; Weller M J Neuroimmunol; 1998 Jul; 87(1-2):121-9. PubMed ID: 9670853 [TBL] [Abstract][Full Text] [Related]
12. CD95 ligand: lethal weapon against malignant glioma? Weller M; Kleihues P; Dichgans J; Ohgaki H Brain Pathol; 1998 Apr; 8(2):285-93. PubMed ID: 9546287 [TBL] [Abstract][Full Text] [Related]
13. Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells. Schlapbach R; Fontana A Biochim Biophys Acta; 1997 Nov; 1359(2):174-80. PubMed ID: 9409814 [TBL] [Abstract][Full Text] [Related]
14. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis. Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719 [TBL] [Abstract][Full Text] [Related]